ACTIVE

PanTera

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-3,9 M €+54,7 %over 1 year

Revenue13,3 M €+731,4 %over 1 year

Equity108,8 M €+34,4 %over 1 year

Workforce24,2 ETP+132,7 %over 1 year

Identity

Source · BCE/KBO

PanTera is a Public limited company incorporated in 2022. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mol. It employs on average 24,2 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0784.992.591
Incorporation: 20/04/2022
Legal form: Public limited company
Registered office: Boeretang 192
2400 Mol · FlandreSee on map
Contributed capital: 122 452 299,58 €
Latest accounts: 31/12/2025
Average workforce: 24,2 ETP

Activities (NACE)

21209Manufacture of pharmaceutical preparations· main 21209Manufacture of pharmaceutical preparations 74909Other professional, scientific and technical activities n.e.c.74999Other professional, scientific and technical activities n.e.c.72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering

Joint committees (1)

Signals

Solid equityLow riskGood liquidityHealthy social debtsHigh revenue

Financials

Source · NBB, 4 filings

Trend over 3 financial years

	2025		2024		2023
Income statement
Revenue	13,3 M €	+731%	1,6 M €	+4064%	38,4 k €
EBITDA	-1,6 M €	+58.0%	-3,8 M €	-410%	-752,5 k €
Operating result	-3,6 M €	+27.8%	-5,1 M €	-371%	-1,1 M €
Net result	-3,9 M €	+54.7%	-8,6 M €	-677%	-1,1 M €
Balance sheet
Equity	108,8 M €	+34.4%	81 M €	+101%	40,2 M €
Total assets	115,8 M €	+34.7%	85,9 M €	+93.6%	44,4 M €
Cash	34,1 M €	+39.2%	24,5 M €	+2166%	1,1 M €
Debts	6,5 M €	+30.9%	5 M €	+20.3%	4,1 M €
Other
Workforce	24,2 ETP	+133%	10,4 ETP	+73.3%	6,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Catherine Vandenborre	Director24/11/2025 → 10/09/2030
Thomas Pevenage	Director20/03/2025 → 10/09/2030
Henri de Romrée de Vichenet	Director10/09/2024 → 10/09/2030
Jean-François Rivassou	Director10/09/2024 → 10/09/2030
Karen Verwimp	Director16/11/2023 → 10/09/2030
Martijn Kleijwegt	Director10/09/2024 → 10/09/2030
Pascal De Langhe	Director19/04/2022 → 10/09/2030
PRIMIX BIO VENTURES0476.755.691Represented by Luc DOCHEZ	Director10/09/2024 → 10/09/2030
Soumya Chandramouli	Director19/04/2022 → 01/06/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Henri de Romrée	Directorlisted until the 2023 accounts
Cristiana Gameiro-Paris	Director16/11/2023 → 2023 accounts
Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire0406.568.867Represented by Peter BAETEN	Director10/07/2023 → 2023 accounts

Full financial information

Source · NBB

	2025	2024	2023
Type of account	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	20/04/2022
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023
Length of the financial year	12 months	12 months	21 months
Filing date	08/09/2026	20/06/2025	23/07/2024
General meeting	04/06/2026	30/04/2025	28/06/2024
Currency of the financial year	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings

Model	Closing	General meeting	Filed	Language	Document
Full modelCorrection	31/12/2025	04/06/2026	08/09/2026	Dutch	PDF
Full model	31/12/2025	04/06/2026	01/07/2026	Dutch	PDF
Full model	31/12/2024	30/04/2025	20/06/2025	Dutch	PDF
Full model	31/12/2023	28/06/2024	23/07/2024	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Catherine Vandenborre	Director24/11/2025 → 10/09/2030
Thomas Pevenage	Director20/03/2025 → 10/09/2030
Henri de Romrée de Vichenet	Director10/09/2024 → 10/09/2030
Jean-François Rivassou	Director10/09/2024 → 10/09/2030
Karen Verwimp	Director16/11/2023 → 10/09/2030
Martijn Kleijwegt	Director10/09/2024 → 10/09/2030
Pascal De Langhe	Director19/04/2022 → 10/09/2030
PRIMIX BIO VENTURES0476.755.691Represented by Luc DOCHEZ	Director10/09/2024 → 10/09/2030
Soumya Chandramouli	Director19/04/2022 → 01/06/2028

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Henri de Romrée	Directorlisted until the 2023 accounts
Cristiana Gameiro-Paris	Director16/11/2023 → 2023 accounts
Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire0406.568.867Represented by Peter BAETEN	Director10/07/2023 → 2023 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office27/05/2026
MAATSCHAPPELIJKE ZETEL
PDF
Capital / shares26/08/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Capital / shares19/12/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Mandates20/09/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/08/2024
ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares05/04/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
PDF
Mandates18/12/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/11/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings3 filings

Mandates

Catherine Vandenborre

Thomas Pevenage

PRIMIX BIO VENTURES

Pascal De Langhe

Soumya Chandramouli

Jean-François Rivassou

Henri de Romrée de Vichenet

Karen Verwimp

Martijn Kleijwegt

Henri de Romrée

Cristiana Gameiro-Paris

Studiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire

202220232024202520262027202820292030

PanTera

Boeretang 201, 2400 Mol

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Boeretang 192, 2400 MolCurrent		CBE
Boeretang 201, 2400 Mol	accounts 2023 → 2025	Accounts 2025 · 2026-00510849

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
PanTeraCurrent	accounts 2023 → 2025	Accounts 2025 · 2026-00510849

Events

2025
Annual accounts 2025-3,9 M €↑
13/08/2025
augmentation_capital
2024
Annual accounts 2024-8,6 M €↓
06/12/2024
augmentation_capital
10/09/2024
augmentation_capital
10/09/2024
augmentation_capital
10/09/2024
augmentation_capital
01/07/2024
nominationSven Van den Berghe · persoon belast met het dagelijks bestuur
21/03/2024
apport
21/03/2024
augmentation_capital
21/03/2024
autre
16/01/2024
nominationRomain Seffer · commissaris
2023
Annual accounts 2023-1,1 M €
16/11/2023
nominationLEGRAIN Olivier Jacques Ghislain · bestuurder
16/11/2023
nominationGAMEIRO-PARIS Cristiana · bestuurder
16/11/2023
nominationVERWIMP Karen Magdalena Frans · bestuurder
01/06/2022
nominationSven Van den Berghe · CEO
20/04/2022
IncorporationPublic limited company
19/04/2022
nominationCHANDRAMOULI Soumya · bestuurder
19/04/2022
nominationSCUTNAIRE Bruno · bestuurder
19/04/2022
nominationBAETEN Peter Hendrik · bestuurder
19/04/2022
nominationDE LANGHE Pascal · bestuurder
19/04/2022
apportSTUDIECENTRUM VOOR KERNENERGIE - CENTRE D'ETUDE DE L'ENERGIE NUCLÉAIRE
19/04/2022
apportION BEAM APPLICATIONS
19/04/2022
constitutionSTUDIECENTRUM VOOR KERNENERGIE - CENTRE D'ETUDE DE L'ENERGIE NUCLÉAIRE · founder
19/04/2022
constitutionION BEAM APPLICATIONS · founder

PanTera

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events